Literature DB >> 2024450

Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.

K W Schmid1, A Hittmair, D Ladurner, P Sandbichler, R Gasser, M Tötsch.   

Abstract

Routinely processed parathyroid tissues from 26 cases with primary hyperparathyroidism (19 adenomas, 7 multiglandular hyperplasia) and 8 normal human parathyroid glands were investigated with antibodies against chromogranin A and B and parathyroid hormone (PTH). Normal parathyroids were immunohistochemically positive for PTH and chromogranin A but negative for chromogranin B. Hyperplastic glands showed a focal staining for PTH and chromogranin A without correlation of the staining pattern on serial sections. Adenomas were either uniformly positive for both PTH and chromogranin A or showed a staining pattern similar to that seen in hyperplastic glands. Focal chromogranin B positivity (less than 10% of cells) was found in 3 cases (1 hyperplastic gland and 2 cases of parathyroid adenoma with an immunohistochemical staining pattern similar to hyperplastic glands). Our immunohistochemical results may support previously published findings that most parathyroid adenomas are monoclonal neoplasms whereas hyperplastic glands are of polyclonal origin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024450     DOI: 10.1007/bf01600157

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  34 in total

Review 1.  Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.

Authors:  B Wiedenmann; W B Huttner
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

2.  Immunological characterization of secretory proteins of chromaffin granules: chromogranins A, chromogranins B, and enkephalin-containing peptides.

Authors:  R Fischer-Colbrie; I Frischenschlager
Journal:  J Neurochem       Date:  1985-06       Impact factor: 5.372

3.  Specific endocrine tissue marker defined by a monoclonal antibody.

Authors:  R V Lloyd; B S Wilson
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

4.  Chromogranin A and B messenger ribonucleic acids in pituitary and other normal and neoplastic human endocrine tissues.

Authors:  R V Lloyd; A Iacangelo; L E Eiden; M Cano; L Jin; M Grimes
Journal:  Lab Invest       Date:  1989-04       Impact factor: 5.662

5.  Chromogranin A, B, and C in human adrenal medulla and endocrine tissues.

Authors:  C Hagn; K W Schmid; R Fischer-Colbrie; H Winkler
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

6.  Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value.

Authors:  K Sekiya; M A Ghatei; M J Salahuddin; A E Bishop; Q A Hamid; H Ibayashi; J M Polak; S R Bloom
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

7.  Secretion from chromaffin cells is controlled by chromogranin A-derived peptides.

Authors:  J P Simon; M F Bader; D Aunis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Inhibition of endogenous peroxidase for the immunocytochemical demonstration of intermediate filament proteins (IFP).

Authors:  A Hittmair; K W Schmid
Journal:  J Immunol Methods       Date:  1989-01-17       Impact factor: 2.303

9.  Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues.

Authors:  D T O'Connor; D Burton; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

10.  Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway.

Authors:  P Rosa; A Hille; R W Lee; A Zanini; P De Camilli; W B Huttner
Journal:  J Cell Biol       Date:  1985-11       Impact factor: 10.539

View more
  6 in total

1.  Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues.

Authors:  A G Naccarato; C Marcocci; P Miccoli; A G Bonadio; L Cianferotti; E Vignali; G Cipollini; P Viacava
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

Review 2.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

3.  Normocalcemic primary hyperparathyroidism in patients with recurrent kidney stones: pathological analysis of parathyroid glands.

Authors:  An-Hang Yang; Chih-Wei Hsu; Jui-Yu Chen; Ling-Ming Tseng; Ging-Shing Won; Chen-Hsen Lee
Journal:  Virchows Arch       Date:  2006-05-03       Impact factor: 4.064

4.  Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues.

Authors:  K W Schmid; B Kunk; R Kirchmair; M Tötsch; W Böcker; R Fischer-Colbrie
Journal:  Histochem J       Date:  1995-06

5.  Immunoreactive Characteristics and Classification of Hyperparathyroidism.

Authors:  Liang Shan; Arata Iwasaki; Hirotoshi Utsunomiya; Ichiro Kawano; Nariaki Matsuura; Akira Kobayashi; Kanji Kuma; Kennichi Kakudo
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

6.  Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study.

Authors:  Ashraf Khan; Arthur S Tischler; Nilima A Patwardhan; Ronald A DeLellis
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.